OrbiMed’s Ascendis Pharma ASND Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$5.94M	Buy	+34,400	New	+$5.94M	0.15%	72
2021 Q3	–	Sell	-447,859	Closed	-$58.9M	–	170
2021 Q2	$58.9M	Sell	447,859 -57,300	-11%	-$7.54M	0.6%	50
2021 Q1	$65.1M	Buy	505,159 +168,659	+50%	+$21.7M	0.61%	48
2020 Q4	$56.1M	Sell	336,500 -398,000	-54%	-$66.4M	0.49%	58
2020 Q3	$113M	Sell	734,500 -828,486	-53%	-$128M	1.42%	21
2020 Q2	$231M	Sell	1,562,986 -1,724,414	-52%	-$255M	3.25%	4
2020 Q1	$370M	Sell	3,287,400 -55,700	-2%	-$6.27M	6.22%	1
2019 Q4	$465M	Sell	3,343,100 -376,073	-10%	-$52.3M	6.64%	1
2019 Q3	$358M	Sell	3,719,173 -127,500	-3%	-$12.3M	6.8%	1
2019 Q2	$443M	Sell	3,846,673 -124,000	-3%	-$14.3M	6.86%	1
2019 Q1	$467M	Sell	3,970,673 -116,700	-3%	-$13.7M	7.23%	1
2018 Q4	$256M	Sell	4,087,373 -68,518	-2%	-$4.29M	4.74%	2
2018 Q3	$294M	Sell	4,155,891 -257,400	-6%	-$18.2M	3.55%	6
2018 Q2	$294M	Buy	4,413,291 +1,045,976	+31%	+$69.6M	3.5%	6
2018 Q1	$220M	Hold	3,367,315	–	–	2.73%	9
2017 Q4	$135M	Hold	3,367,315	–	–	1.71%	17
2017 Q3	$122M	Hold	3,367,315	–	–	1.17%	28
2017 Q2	$93.5M	Buy	3,367,315 +650,000	+24%	+$18M	0.98%	30
2017 Q1	$76.1M	Hold	2,717,315	–	–	0.86%	38
2016 Q4	$55M	Buy	2,717,315 +526,315	+24%	+$10.7M	0.7%	45
2016 Q3	$44M	Hold	2,191,000	–	–	0.5%	56
2016 Q2	$29.1M	Buy	2,191,000 +1,968,777	+886%	+$26.1M	0.3%	63
2016 Q1	$4.12M	Hold	222,223	–	–	0.04%	120
2015 Q4	$4.07M	Hold	222,223	–	–	0.04%	110
2015 Q3	$3.93M	Sell	222,223 -1,226,768	-85%	-$21.7M	0.04%	113
2015 Q2	$25.6M	Hold	1,448,991	–	–	0.21%	75
2015 Q1	$25.1M	Buy	+1,448,991	New	+$25.1M	0.21%	71